children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405–421.
Kim, H.W., J.G.Canchola, C.D.Brandt, G.Pyles, R.M.Chanock, K. Jensen, and R.H.Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422–434.
Kim, H.W., J.O.Arrobio, C.D.Brandt, P.Wright, D.Hodes, R.M. Chanock, and R.H.Parrott. 1973. Safety and antigenicity of temperature sensitive (ts) mutant respiratory syncytial virus (RSV) in infants and children. Pediatrics 52:56–63.
MacDonald, N.E., C.B.Hall, S.C.Suffin, C.Alexson, P.J.Harris, and J.A.Manning. 1982. Respiratory syncytial virus infection in infants with congenital heart disease. N. Engl. J. Med. 307(7):397–400.
Mills, J., J.E.VanKirk, P.F.Wright, and R.M.Chanock. 1971. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J. Immunol. 107:123–130.
Parrott, R.H., H.W.Kim, J.O.Arrobio, D.S.Hodes, B.R.Murphy, C.D. Brandt, E.Camargo, and R.M.Chanock. 1973. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am. J. Epidemiol. 98:289–300.
Tyeryar, F.J. 1983. Report of a workshop on respiratory syncytial virus and parainfluenza viruses. J. Infect. Dis. 148(3):588–598.
Venkatesan, S., N.Elango, and R.M.Chanock. 1983. Construction and characterization of cDNA clones for four respiratory syncytial viral genes. Proc. Natl. Acad. Sci. 80(5):1280–1284.
Walsh, E.E., and J.Hruska. 1983. Monoclonal antibodies to respiratory syncytial virus proteins. Identification of the fusion protein. J. Virol. 47(1):171–177.
Wright, P.F., T.Shinozaki, W.Fleet, S.H.Sell, J.Thompson, and D.T. Karzon. 1976. Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J. Pediatr. 88(6):931–936.